# HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
> **ANDA083770** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS
## Drug
- **FDA Application Number:** ANDA083770
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
- **Generic name:** Hydralazine Hydrochloride
- **Active ingredients:** HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** WATSON LABS
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083770)
---
*MORVS · CC0 1.0*